iCliniq Logo
HomeHealth articlesDiabetologytype 1 diabetes mellitus

Genetics and Their Role in Type 1 Diabetes - An Insight

Verified data
0

4 min read

Share

Outline

Genetic factors strongly affect type 1 diabetes. Certain genes increase susceptibility, and environmental factors can trigger the autoimmune process.

Written byDr. Kinjal Shah

Medically reviewed byDr. Nagaraj Malipatil

Published At August 20, 2024
Reviewed AtDecember 31, 2025

Is Type 1 Diabetes Genetic?

Type 1 diabetes (T1D) is known to be influenced by genes inherited from our parents; however, the disease develops gradually in the body, and symptoms may not appear for years. Researchers have also looked into environmental risk factors that may cause type 1 diabetes because the majority of people, even those with T1D risk factors, simply do not develop the disease.

The major risk genes exist within the human leukocyte antigen complex (HLA) and contribute nearly half of the genetic risk. More genes and strong family histories add to the risk of someone acquiring type 1 diabetes. Having type 1 diabetes can increase one's risk if their parent or sibling also has type 1 diabetes. Nevertheless, type 1 diabetes can occur among those who do not have a strong family history.

Genetic Components and Type 1 Diabetes

The HLA genes create the proteins that your immune system needs to remain strong. Type 1 diabetes is an autoimmune disorder, which means that your immune system is fighting the cells that produce insulin. It is not surprising that HLA genes are prominent. Genetic factors influencing type 1 diabetes.

1. Family history

A family history of type 1 diabetes may raise the likelihood of getting the disease, as is the case with many medical disorders. People who have a parent or sibling with type 1 diabetes may be more at risk. The American Diabetes Association states that if both parents have type 1 diabetes, the child's risk of developing the disease might be as high as 1 in 4.

2. The molecules of the major histocompatibility complex (MHC)

A set of genes known as the major histocompatibility complex is present in both humans and animals, helping the immune system identify foreign substances. It has been found that the genetic background of type 1 diabetes is followed by the presence of major histocompatibility complex (MHC) proteins on particular chromosomes.

3. Autoantibodies in circulation

Antibodies are a normal and essential immune system response to external dangers. On the other hand, autoantibodies show that the body is reacting to its own healthy cells with an autoimmune response. Earlier research has demonstrated that individuals with type 1 diabetes have multiple forms of autoantibodies.

Diabetes Odds

The odds of your child developing type 1 diabetes are roughly 1 in 17.

For new mothers who have type 1 diabetes:

  • The child's risks double if the parent develops diabetes before the age of eleven, as type 1 diabetes is genetic.

  • At age 25, the child's odds are about the same as everybody else's, at 1 in 100, as diabetes is hereditary.

Several factors can increase such chances:

  • The child's risks double if the parent develops diabetes before the age of eleven, as the child can be born with diabetes.

  • The risk may be as high as one in four if both parents have it.

  • Because type 1 diabetes is inherited, there is a one in two chance that a child will also have type 2 polyglandular autoimmune syndrome (it is a condition in which there is adrenal insufficiency).

Can My Sibling Have Type 1 Diabetes?

One has a roughly five percent chance of developing type 1 diabetes if a brother or sister has it, but your parents do not. It would be about equivalent to if your father had it. However, your chances could be as high as 50 percent if your identical twin has it.

Is There a Cure for Type 1 Diabetes?

As of right now, Type 1 diabetes has no known treatment. Through research, scientists are exploring ways to halt or slow its progression.

Type 1 diabetes can be inherited. Your healthcare provider might test your family members for the autoantibodies that cause the disease. Type 1 diabetes also provides this testing.

Having autoantibodies, even without symptoms of diabetes, increases the likelihood of developing the condition. If someone shows early signs of autoantibodies, they may be able to take a medication that delays type 1 diabetes. This medication is called Teplizumab. It can postpone the onset of T1D symptoms and the need for insulin injections. If it is an infusion given once a day over several days.

Two types of transplants may cure T1D. However, they come with serious risks, such as complications from surgery and health issues related to taking immunosuppressants. Providers only recommend them for a limited number of people with T1D. The transplants include:

  • Islet cell transplant: Researchers are experimenting with islet cell transplantation. This procedure involves the use of new insulin-producing cells derived from a donor pancreas. It had difficulties in the past, but new methods and improved medications to stop islet cell rejection might increase the likelihood that it will work as a treatment.

  • Pancreas transplant: People with extremely difficult-to-manage diabetes are typically offered pancreas transplants because these risks may be more dangerous than diabetes itself. Those in need of a kidney transplant can also use them. You would not require insulin after a successful pancreas transplant. However, there are serious risks associated with pancreas transplants, and they may not always be successful.

What Are Recent Advances in Genetic Research on Type 1 Diabetes?

Recent research on type 1 diabetes (T1D) focuses on new ways to restore insulin function. This includes developing cell-based therapies such as stem cells and encapsulated islets, and FDA approval for treatments like allogeneic islet cell therapy (Lantidra). Advanced gene editing, like CRISPR, can help the immune system and regenerate insulin-producing cells. Other progress includes predicting personal risk, developing long-lasting treatments beyond insulin, and determining how epigenetics and the microbiome can affect the start of the disease.

Conclusion

The autoimmune disease commonly referred to as type 1 diabetes is caused by both genetic and environmental components. The risk of developing the disease is contributed to by particular genes, especially those connected with the immune system. The immune system reaction responsible for causing type 1 diabetes can also result from environmental elements, for example, contact with viruses and climate. To know more, you can consult our Diabetic specialist.

Key Takeaways

  • Type 1 diabetes is an autoimmune disease influenced by genetic components and triggered by external factors.

  • An increased risk of Type 1 diabetes is also linked with particular genes, for example, those that affect the immune system.

  • It has also been proposed that living in specific climates and being exposed to viruses are external factors that can lead to autoimmunity.

  • It would help immensely for people who have type 1 diabetes, as managing it would make their lives easier.

Listen to related tracks in our music library
Source Article IclonSourcesSource Article Arrow

Tags:

type 1 diabetes mellitusgenetics

Ask your health query to a doctor online

Diabetology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.